Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions 
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Wall Street Ends Lower as AI Stocks Drag Markets, Fed Rate Outlook Shifts 
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access 
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO 
Wall Street Ends Mixed as Micron Surges, Apple Drops After Price Hikes 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
U.S. Dollar Reaches One-Year High as Tech Sell-Off and Fed Rate Hike Expectations Support Demand 
US Dollar Slips After PCE Inflation Data as Fed Rate Hike Expectations Stay Elevated 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Why the future of marijuana legalization remains hazy despite high public support 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Asian Stocks Sink as Apple Price Hikes Spark AI Valuation Fears, South Korea and Japan Lead Selloff 
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
